Understanding the immune correlates of protection in infected individuals with a mild form of COVID-19 versus those with the severe form of the disease is essential for therapeutic interventions or vaccine design.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$0Funder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Shokrollah ElahiResearch Location
CanadaLead Research Institution
University of AlbertaResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Disease pathogenesis
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Understanding the immune correlates of protection in infected individuals with a mild form of COVID-19 versus those with the severe form of the disease is essential for therapeutic interventions or vaccine design.